Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Public Health Pract (Oxf) ; 4: 100277, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36570399

RESUMO

Objectives: Individuals who engage in regular physical activity, consume a healthy diet, have a normal body mass index (BMI), as well as avoid smoking and heavy alcohol consumption have lower risks of morbidity and mortality. While self-reported health is a strong predictor of morbidity and mortality, data are sparse about the interrelationship of concurrent healthy behaviors and self-reported health. Study design: Cross-sectional study design. Methods: The sample included 7,267 individuals aged 30-50 years without diabetes, heart failure, cancer, myocardial infarction, stroke and emphysema from 2009 to 2016 of the National Health and Nutrition Examination Survey (NHANES). We used latent class analyses to identify concurrent healthy behaviors and explore interrelationships of class membership with self-reported health after adjusting for covariates using SAS® 9.4 software. Results: Two mutually exclusive classes were found, "fewer healthy behaviors" and "more healthy behaviors". "Fewer healthy behaviors" class members were less adherent to healthy guidelines while "more healthy behaviors" class members were more adherent. The two classes varied by smoking status, diet, and physical activity but not by BMI or alcohol consumption. Individuals in the "more healthy behaviors" class were associated with self-assessments of good (OR: 2.08; 95% CI: 1.15-3.79), very good (OR: 3.22; 95% CI: 1.78-3.79) and excellent (OR: 4.09; 95% CI: 2.11-7.94) health compared to those in the "fewer healthy behavior" class. Conclusions: We revealed two mutual exclusive classes with differing patterns of healthy behavior adherence. The class of individuals with more concurrent healthy behavior recommendations were more likely to self-assess their health more favorably.

2.
Public Health Nutr ; 25(11): 3225-3234, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-35899785

RESUMO

OBJECTIVE: To explore whether individuals who consume higher amounts of ultra-processed food (UPF) have more adverse mental health symptoms. DESIGN: Using a cross-sectional design, we measured the consumption of UPF as a percentage of total energy intake in kilo-calories using the NOVA food classification system. We explored whether individuals who consume higher amounts of UPF were more likely to report mild depression, more mentally unhealthy days and more anxious days per month using multivariable analyses adjusting for potential confounding variables. SETTING: Representative sample from the United States National Health and Nutrition Examination Survey between 2007 and 2012. PARTICIPANTS: 10 359 adults aged 18+ without a history of cocaine, methamphetamine or heroin use. RESULTS: After adjusting for covariates, individuals with the highest level of UPF consumption were significantly more likely to report at least mild depression (OR: 1·81; 95 % CI1·09, 3·02), more mentally unhealthy (risk ratio (RR): 1·22; 95 % CI 1·18, 1·25) and more anxious days per month (RR: 1·19; 95 % CI 1·16, 1·23). They were also significantly less likely to report zero mentally unhealthy (OR: 0·60; 95 % CI 0·41, 0·88) or anxious days (OR: 0·65; 95 % CI 0·47, 0·90). CONCLUSIONS: Individuals reporting higher intakes of UPF were significantly more likely to report mild depression, more mentally unhealthy and more anxious days and less likely to report zero mentally unhealthy or anxious days. These data add important information to a growing body of evidence concerning the potential adverse effects of UPF consumption on mental health.


Assuntos
Cocaína , Metanfetamina , Adulto , Estudos Transversais , Dieta/efeitos adversos , Ingestão de Energia , Fast Foods/efeitos adversos , Manipulação de Alimentos , Heroína , Humanos , Saúde Mental , Inquéritos Nutricionais
3.
J Arthroplasty ; 37(12): 2317-2322, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-35760255

RESUMO

BACKGROUND: Severe obesity is associated with complications following arthroplasty, leading surgeons to increasingly counsel patients regarding weight loss. For patients seeking arthroplasty, learning that severe obesity may be a relative contraindication to surgery can create a challenging clinical interaction. We sought to describe the self-reported health of United States (US) adults who had severe obesity and osteoarthritis (OA) to better understand patient perspectives. METHODS: The National Health and Nutrition Examination Survey, a nationally representative sample of the US population, was used to identify adult participants who had a body mass index (BMI) over 35 and an OA diagnosis. In total, 889 participants representing a US population of 9,604,722 were included. Self-reported health was dichotomized as poor to fair versus good to excellent. Analyses were weighted to produce national estimates. Associations between obesity severity and patient characteristics with self-reported health were assessed. RESULTS: Of US adults with a BMI over 35 and OA diagnosis, 64% rated their health as good or better. For adults who had a BMI over 45, 55% still reported their health as good or better. The strongest predictors of self-reported health were measures of physical functioning. Only 37% of participants who had much difficulty walking a quarter mile rated their health as good or better compared to 86% without difficulty (P < .001). CONCLUSION: Approximately two-thirds of patients who have severe obesity and OA do not perceive their health as compromised and consider decreased physical function as the primary driver of decreased health. This suggests that counseling about the association between obesity and overall health may improve shared decision making and that patient satisfaction metrics may be difficult to interpret in these clinical situations.


Assuntos
Obesidade Mórbida , Osteoartrite , Adulto , Estados Unidos/epidemiologia , Humanos , Obesidade Mórbida/complicações , Obesidade Mórbida/epidemiologia , Autorrelato , Inquéritos Nutricionais , Obesidade/complicações , Obesidade/epidemiologia , Índice de Massa Corporal , Osteoartrite/epidemiologia , Osteoartrite/cirurgia , Osteoartrite/complicações
4.
Pediatr Obes ; 17(9): e12924, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35501286

RESUMO

BACKGROUND: Non-alcoholic fatty liver conditions in adolescence are associated with premature mortality in adulthood. Effective screening could impact the population burden of this disease. OBJECTIVES: We sought to determine which adolescents should be screened for non-alcoholic fatty liver using vibration-controlled transient elastography. METHODS: We simulated a non-alcoholic fatty liver screening program of 938 adolescents from the National Health and Nutritional Examination Survey of 2017/2018. We stratified subjects by body mass index and metabolic parameters and analyzed our data using standard diagnostic statistical measures. RESULTS: The weighted prevalence of non-alcoholic fatty liver and non-alcoholic fatty liver disease was 24.4%, and 3.8%, respectively. For all subjects with obesity (21.8% of the population), screening identified 61.8% of the non-alcoholic fatty liver cases. In a category of all subjects with obesity and overweight subjects with metabolic abnormalities (26.7% of the population), screening identified 71.2% of non-alcoholic fatty liver cases. CONCLUSIONS: The two groups most likely to benefit by transient elastography screening are adolescents with obesity and overweight adolescents with one metabolic abnormality. These criteria reduce the number of individuals to be tested by approximately 80% (from an approximate 32 million adolescents to 6-7.5 million adolescents), while retaining a diagnostic accuracy of 84%-85%.


Assuntos
Hepatopatia Gordurosa não Alcoólica , Adolescente , Adulto , Índice de Massa Corporal , Humanos , Hepatopatia Gordurosa não Alcoólica/complicações , Hepatopatia Gordurosa não Alcoólica/diagnóstico , Hepatopatia Gordurosa não Alcoólica/epidemiologia , Obesidade/complicações , Obesidade/diagnóstico , Obesidade/epidemiologia , Sobrepeso/epidemiologia , Medição de Risco
5.
Clin Pediatr (Phila) ; 60(8): 370-375, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-34100658

RESUMO

Nonalcoholic fatty liver disease (NAFLD) is common in overweight adolescents, and screening with serum alanine transaminase (ALT) levels is recommended by the American Academy of Pediatrics. We sought to determine if ALT is an accurate adolescent screening measure for NAFLD in a nationally representative sample of overweight adolescents. Diagnosis of NAFLD was determined using vibration-controlled transient elastography. Analyses were performed to calculate the sensitivity, specificity, positive predictive value, negative predictive value, and Youden's index at various serum ALT cutoff levels. Receiver operating curves were generated in order to determine ALT's discrimination capability. Males and females were analyzed separately. While average measures (mean and median) of ALT were higher in subjects with NAFLD, ALT provided only minimal discrimination with AUROC (area under the receiver operating characteristic) values of .66 in males and .67 in females. In a nationally representative sample of overweight and obese adolescents, serum ALT level functioned inadequately as a screening test to detect NAFLD.


Assuntos
Alanina Transaminase/sangue , Hepatopatia Gordurosa não Alcoólica/sangue , Hepatopatia Gordurosa não Alcoólica/diagnóstico , Inquéritos Nutricionais/métodos , Sobrepeso/complicações , Adolescente , Adulto , Biomarcadores/sangue , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Hepatopatia Gordurosa não Alcoólica/complicações , Inquéritos Nutricionais/estatística & dados numéricos , Sobrepeso/sangue , Reprodutibilidade dos Testes , Adulto Jovem
6.
South Med J ; 114(5): 261-265, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33942107

RESUMO

OBJECTIVES: Lifestyle behaviors relevant to cardiovascular health are learned during childhood and continued into adulthood. Children and adolescents who participate in unhealthy behaviors have a higher lifetime risk of cardiovascular disease in adulthood. Public health institutions publish behavior and clinical recommendations designed for adolescents to reduce their lifetime cardiovascular risk. We assessed the prevalence and trends of cardiovascular-relevant behaviors and clinical tests among early adolescents using a nationally representative database. METHODS: In 2020, we compared the prevalence of cardiovascular risk factors among 1408 adolescents surveyed from 1988 to 1994 with that of 1812 adolescents surveyed from 2011 to 2016 by obtaining and comparing measures on physical activity, diet, body mass index, smoking status, cholesterol levels, hemoglobin A1c, sodium intake, and blood pressure. RESULTS: The prevalence of adherence to the current recommendations regarding physical activity, diet, and body weight declined over time. Conversely, the prevalence of adhering to recommendations to avoid smoking increased. Clinical indicators, including blood pressure control and normal measures of hemoglobin A1c and total serum cholesterol, showed mixed results, with more individuals showing signs of hyperglycemia, fewer showing signs of hypercholesterolemia, and the percentage of individuals with abnormal blood pressure remaining the same. The use of cardiometabolic medications also increased during the study period. Finally, the number of adolescents with all seven cardiovascular protective factors declined significantly during the study period, from 27.6% to 9.6%. CONCLUSIONS: Modern American teenagers aged 12 to 16 years have more cardiovascular risk factors relating mostly to diet, exercise, and obesity than those of a prior generation; however, smoking rates have also declined precipitously.


Assuntos
Fatores de Risco de Doenças Cardíacas , Adolescente , Pressão Sanguínea , Índice de Massa Corporal , Criança , Colesterol/sangue , Dieta/estatística & dados numéricos , Exercício Físico , Feminino , Hemoglobinas Glicadas/análise , Humanos , Masculino , Inquéritos Nutricionais , Prevalência , Fumar/epidemiologia , Sódio na Dieta/administração & dosagem , Estados Unidos/epidemiologia
7.
Int J Clin Pharm ; 42(6): 1533-1536, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32876828

RESUMO

Long standing concerns regarding the use of medications during pregnancy and their unknown effects on fetal development and child health suggests the need for modified study methods regarding the establishment of drug safety for the fetus. This Current Commentary highlights several pharmacological study method limitations and offers suggestions for the establishment of drug safety for the fetus. For example, extensive phase 1 pharmacology studies are needed to assess the complex pharmacokinetic relationships between mother and fetus in order to determine injurious doses to the fetus throughout pregnancy. In addition, long term randomized clinical trials are needed to assess the effects medications may have on children following exposure during gestation.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia , Feto/efeitos dos fármacos , Exposição Materna/efeitos adversos , Troca Materno-Fetal , Feminino , Idade Gestacional , Humanos , Farmacocinética , Gravidez , Medição de Risco , Fatores de Risco , Toxicocinética
9.
Am J Prev Med ; 59(2): 270-273, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32340777

RESUMO

INTRODUCTION: Leading public health institutions recommend participation in several evidence-based behaviors, including exercise, a healthy diet, and maintenance of a normal BMI while simultaneously avoiding cigarette smoking and excessive alcohol consumption. The investigators attempted to evaluate the collective adherence to these recommendations and population trends in these behaviors by evaluating nationally representative surveys over a period of 12 years. METHODS: In 2019, the data from 26,194 National Health and Examination Survey participants who provided answers to survey questions regarding diet, physical activity, and usage of cigarettes and alcohol were analyzed. BMI was obtained from the examination data. Adherence to each behavior and the constellation of all 5 behaviors was assessed and tracked over a 12-year timeframe. RESULTS: The smoking rates (p=0.01) and adherence to a healthy BMI declined over time (p=0.03). The total percentage of subjects who participated in all 5 behaviors ranged from 4.4% to 6.3%, whereas subjects who performed 2 or fewer behaviors ranged from 45.4% to 48.3%. Greater education (p<0.0001), higher SES (p<0.0001), and being a female participant (p<0.0001) predicted higher behavior scores. CONCLUSIONS: Only 1 in 5 Americans engage in 4 or more healthy behaviors, whereas almost half of them participate in fewer than 3 healthy behaviors. Increased participation in numerous healthy behaviors can decrease premature mortality, decrease the burden of chronic diseases, improve life quality, and provide substantial economic benefits. A public health practice of targeting a constellation of behaviors as opposed to individual behaviors is needed.


Assuntos
Comportamentos Relacionados com a Saúde , Assunção de Riscos , Consumo de Bebidas Alcoólicas/epidemiologia , Exercício Físico , Feminino , Humanos , Masculino , Inquéritos Nutricionais , Fumar/epidemiologia , Estados Unidos/epidemiologia
10.
Home Healthc Now ; 36(2): 103-113, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29498990

RESUMO

Home healthcare aides (HHAs) are a growing U.S. workforce highly susceptible to workplace stressors and musculoskeletal pain. In the present study we: 1) examine the association of musculoskeletal pain to life satisfaction and emotional exhaustion; and 2) characterize interest in meditation and yoga in a sample of HHAs. A nonprobabilistic sample of HHAs employed at home healthcare agencies in Florida, Massachusetts, and Oregon (n = 285 total) completed a self-administered questionnaire with standard survey measures on musculoskeletal pain location, duration, and severity; life satisfaction; emotional exhaustion; and interest in meditation techniques and yoga. Among HHAs responding, 48.4% reported pain in the last 7 days and 46.6% reported pain in the last 3 months. Home healthcare aides who reported current pain and chronic pain had a significant (P < .05) decrease in satisfaction with life score and a significant increase in emotional exhaustion score. The majority of HHAs reported an interest in learning about the benefits (65.6%) and practice (66.4%) of meditation and a willingness to participate in a yoga class (59.2%) or stress management meeting (59.1%). The HHAs reported both acute and chronic musculoskeletal pain that was correlated with lower life satisfaction and greater emotional exhaustion. More efforts are needed to reduce the sources of injury and emotional exhaustion.


Assuntos
Esgotamento Profissional/reabilitação , Visitadores Domiciliares/psicologia , Meditação/psicologia , Dor Musculoesquelética/reabilitação , Inquéritos e Questionários , Yoga/psicologia , Adulto , Atitude do Pessoal de Saúde , Estudos Transversais , Feminino , Agências de Assistência Domiciliar/organização & administração , Humanos , Masculino , Pessoa de Meia-Idade , Dor Musculoesquelética/fisiopatologia , Dor Musculoesquelética/psicologia , Doenças Profissionais/terapia , Exame Físico/métodos , Projetos Piloto , Qualidade de Vida , Medição de Risco , Fatores Socioeconômicos
11.
Arch Environ Occup Health ; 73(6): 355-359, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28876189

RESUMO

As the US population ages, there is an expected increase in demand for home health aides (HHAs); therefore, it is important to ensure their occupational well-being. Previous studies have demonstrated associations between negative emotions and musculoskeletal pain. Using survey data collected from 285 HHAs, we characterize the association between affect and musculoskeletal pain. Affect was measured using the Positive and Negative Affect Schedule, while musculoskeletal pain was measured using the Brief Pain Inventory. We found that as positive affect composite score increased, musculoskeletal pain decreased [ß = -0.57, t(124) = -7.01, p < .001]. There was no significant association between the negative affect composite score and musculoskeletal pain. However, several individual moods were associated with decreased or increased pain. These data suggest that some moods may buffer against musculoskeletal pain, while others may predispose HHAs to musculoskeletal pain.


Assuntos
Visitadores Domiciliares/estatística & dados numéricos , Dor Musculoesquelética/epidemiologia , Doenças Profissionais/epidemiologia , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor Musculoesquelética/etiologia , Doenças Profissionais/etiologia , Saúde Ocupacional , Estados Unidos/epidemiologia
12.
Cardiology ; 141(4): 177-182, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30699411

RESUMO

The interrelationships between cadmium biomarker levels, smoking, and myocardial infarction and stroke have been established. In this cross-sectional analysis, we explored the interrelationships of blood cadmium levels, smoking, and angina. We analyzed the National Health and Nutrition Examination Survey (NHANES, 2003-2014) accounting for the multi-staged complex sampling design. Participants 40-79 years of age with blood cadmium levels but without a history of myocardial infarction and/or stroke were included (n = 14,832). We examined blood cadmium levels (3 tertile groups) in relation to 3 (diagnosed, undiagnosed, and composite diagnosed and/or undiagnosed) angina outcomes. Multivariable logistic regression models adjusted for age, diabetes, smoking status, and household income were used to estimate odds ratios (ORs) and their corresponding 95% confidence intervals (CIs). Of 14,832 participants, 741 (4.2%) had positive composite angina. The crude and adjusted ORs comparing those in the lowest tertile (referent group) of blood cadmium to those in the highest tertile for the composite outcome were 1.82 (95% CI 1.42-2.34) and 1.45 (95% CI 1.12-1.88), respectively. These cross-sectional data from a nationally representative sample contribute to the hypothesis that there are interrelationships between smoking, cadmium, and angina.


Assuntos
Angina Pectoris/sangue , Cádmio/sangue , Fumar/sangue , Adulto , Idoso , Angina Pectoris/epidemiologia , Biomarcadores/sangue , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Inquéritos Nutricionais , Razão de Chances , Fumar/epidemiologia , Estados Unidos/epidemiologia
13.
Am J Cardiol ; 118(2): 204-9, 2016 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-27316775

RESUMO

Cadmium biomarker levels are associated with both cigarette smoking and cardiovascular disease. In this cross-sectional survey, we explore whether the association between cadmium and cardiovascular disease differs between cigarette smoking states. A cross-sectional analysis using the National Health and Nutrition Examination Survey in 2003 to 2012 was performed accounting for the nationally representative complex sampling design. All participants 45 to 79 years old with blood and urinary cadmium levels were included (n = 12,511). We explored the inter-relationships of blood and urine cadmium levels with cigarette smoking and a composite cardiovascular outcome that included self-reported myocardial infarction or stroke or both. We used multivariable logistic regressing models to further adjust for age, income, gender, hypercholesterolemia, body mass index, diabetes, smoking intensity, and time period of smoking cessation. Of the 12,511 participants, 1,330 (8.5%) had previous myocardial infarction or stroke or both. The crude prevalence ratio (PR) comparing those in the lowest tertile of blood cadmium with those in the highest tertile for the composite outcome was 1.73 (95% confidence interval [CI] 1.49 to 2.01). After adjustment for age, gender, income, self-reported diabetes, self-reported hypercholesterolemia, body mass index, and smoking status, the PR was 1.54 (95% CI 1.30 to 1.84). The adjusted PRs for each smoking subgroup were 1.54 (95% CI 1.09 to 2.18) for never-smokers, 1.57 (95% CI 1.11 to 2.23) for current smokers, and 1.31 (95% CI 0.96 to 1.78) for former smokers. These descriptive data from a nationally representative sample suggest that cadmium is related to cardiovascular outcomes even after adjustment for smoking status.


Assuntos
Cádmio/metabolismo , Infarto do Miocárdio/metabolismo , Fumar/metabolismo , Acidente Vascular Cerebral/metabolismo , Fatores Etários , Idoso , Índice de Massa Corporal , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/metabolismo , Estudos Transversais , Diabetes Mellitus/epidemiologia , Feminino , Humanos , Hipercolesterolemia/epidemiologia , Renda/estatística & dados numéricos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Infarto do Miocárdio/epidemiologia , Inquéritos Nutricionais , Obesidade/epidemiologia , Prevalência , Fatores Sexuais , Fumar/epidemiologia , Abandono do Hábito de Fumar/estatística & dados numéricos , Acidente Vascular Cerebral/epidemiologia , Fatores de Tempo , Estados Unidos/epidemiologia
14.
Biomarkers ; 21(5): 429-35, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26983064

RESUMO

Cadmium contamination of tobacco may contribute to the health hazards of cigarette smoking. The 2005-2012 United States National Health and Nutrition Examination Survey data provided a unique opportunity to conduct a cross-sectional survey of cadmium biomarkers and cigarette smoking. Among a sample of 6761 participants, we evaluated mean differences and correlations between cadmium biomarkers in the blood and urine and characteristics of never, former and current smokers. We found statistically significant differences in mean cadmium biomarker levels between never and former smokers as well as between never and current smokers. In current smokers, duration in years had a higher correlation coefficient with urinary than blood cadmium levels. In contrast, number of cigarettes smoked per day had a higher correlation coefficient with blood than urinary cadmium levels. These data suggest that blood and urine cadmium biomarker levels differ by duration and dose. These findings should be considered in evaluating any association between cadmium and smoking related diseases, especially cardiovascular disease.


Assuntos
Cádmio/sangue , Cádmio/urina , Fumar , Produtos do Tabaco/toxicidade , Adulto , Biomarcadores/sangue , Biomarcadores/urina , Estudos Transversais , Relação Dose-Resposta a Droga , Feminino , Inquéritos Epidemiológicos , Humanos , Masculino , Pessoa de Meia-Idade , Fumar/sangue , Fumar/urina , Fatores de Tempo , Estados Unidos
15.
Ann Surg Oncol ; 22(10): 3241-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26242363

RESUMO

BACKGROUND: Nipple-sparing mastectomy (NSM) is an increasingly common procedure; however, concerns exist regarding its oncological safety due to the potential for residual breast tissue to harbor occult malignancy or future cancer. METHODS: A systematic literature review was performed. Studies with internal comparison arms evaluating therapeutic NSM versus skin-sparing mastectomy (SSM) and/or modified radical mastectomy (MRM) were included in a meta-analysis of overall survival (OS), disease-free survival (DFS), and local recurrence (LR). Studies lacking comparison arms were only included in the systematic review to evaluate mean OS, DFS, LR, and nipple-areolar recurrence (NAR). RESULTS: The search yielded 851 articles. Twenty studies with 5594 patients met selection criteria. The meta-analysis included eight studies with comparison arms. Seven studies that compared OS found a 3.4% risk difference between NSM and MRM/SSM, five studies that compared DFS found a 9.6% risk difference between NSM and MRM/SSM, and eight studies that compared LR found a 0.4% risk difference between NSM and MRM/SSM. Risk differences for all outcomes were not statistically significant. The systematic review included all 20 studies and evaluated OS, DFS, LR, and NAR. Studies with follow-up intervals of <3 years, 3-5 years, and >5 years had mean OS of 97.2, 97.9, and 86.8%; DFS of 93.1, 92.3, and 76.1%; LR of 5.4, 1.4, and 11.4%; and NAR of 2.1, 1.0, and 3.4%, respectively. CONCLUSIONS: This study did not detect adverse oncologic outcomes of NSM in carefully selected women with early-stage breast cancer. Use of prospective data registries, notably the Nipple-Sparing Mastectomy Registry, will add clarity to this important clinical question.


Assuntos
Neoplasias da Mama/cirurgia , Mastectomia Radical Modificada/efeitos adversos , Recidiva Local de Neoplasia/diagnóstico , Mamilos/cirurgia , Neoplasias da Mama/mortalidade , Intervalo Livre de Doença , Feminino , Humanos , Mamoplastia , Mastectomia Radical Modificada/mortalidade , Recidiva Local de Neoplasia/etiologia , Recidiva Local de Neoplasia/mortalidade , Tratamentos com Preservação do Órgão/mortalidade , Prognóstico , Taxa de Sobrevida
18.
Clin Neuropharmacol ; 37(2): 45-51, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24614671

RESUMO

OBJECTIVE: Patients with multiple sclerosis (MS) taking natalizumab are at risk for progressive multifocal leukoencephalopathy (PML). We sought to describe the outcomes of discontinuing natalizumab on the basis of PML risk and those of obtaining additional screening across a range of scenarios using decision tree models. METHODS: Health state probabilities and values, measured as the proportion of quality-adjusted life years (PQALY) relative to baseline health, were based on literature review. Probabilities of worsening MS while continuing and discontinuing natalizumab were set to 0.23 and 0.44. For discontinuing therapy, PML risk, worsening MS value, and PML value were varied. For additional screening, the probability of discontinuing natalizumab without screening, PML risk, worsening MS value, and PML value were set to 33%, 1.1%, 0.88, and 0.09, respectively, with test sensitivity and specificity varying from 0.50 to 1. RESULTS: Discontinuing natalizumab provided no benefit until PML risk reached 2.9%, assuming an MS relapse value of 0.88 and a PML value of 0.09. Additional screening changed the PQALY by -0.3% to 1.5%, largely influenced by specificity. Assuming a sensitivity of 80% and a specificity of 99%, screening increases the PQALY by 1.2%. CONCLUSIONS: The highest PML risk identified by stratification is below 2.9%, suggesting that continuing natalizumab outweighs PML risk for most patients on the basis of theoretical calculations. However, decisions based on additional screening with high-specificity tests, including polymerase chain reaction cerebrospinal fluid tests for John Cunningham virus, may provide benefit and should be clinically tested. Increased precision of probabilities and quality-of-life values are also needed to improve decision making.


Assuntos
Anticorpos Monoclonais Humanizados/efeitos adversos , Anticorpos Monoclonais Humanizados/uso terapêutico , Árvores de Decisões , Leucoencefalopatia Multifocal Progressiva/diagnóstico , Esclerose Múltipla/tratamento farmacológico , Humanos , Leucoencefalopatia Multifocal Progressiva/induzido quimicamente , Leucoencefalopatia Multifocal Progressiva/complicações , Esclerose Múltipla/complicações , Natalizumab , Anos de Vida Ajustados por Qualidade de Vida , Medição de Risco , Fatores de Risco , Sensibilidade e Especificidade
19.
J Cardiovasc Pharmacol Ther ; 18(6): 550-4, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24038014

RESUMO

INTRODUCTION: Cigarette smoking is a major risk factor for cardiovascular disease via acute and chronic mechanisms, some of which remain unclear. One plausible but untested hypothesis concerns cadmium (Cd), a component of cigarette smoke, which is injurious to vascular endothelial cells and is independently associated with cardiovascular disease. To contribute to the formulation of this hypothesis, we performed a meta-analysis of the available data that consisted of cross-sectional studies useful to formulate but not test hypotheses. METHODS: PubMed and Google Scholar were searched by combining the terms smoking, Cd, correlation, blood, human, and tobacco. Following abstract review, 10 cross-sectional studies were identified. We compared serum Cd levels between smokers and nonsmokers using standardized mean differences (SMDs) as well as correlation coefficients between smoking and Cd. RESULTS: The estimated overall random effects SMD in Cd between smokers and nonsmokers was 1.13 (95% confidence interval [CI], .70-1.56) with significant heterogeneity (Q = 8.6, P < .001). The estimated overall random effects correlation coefficient between smoking and Cd was .54 (95% CI, .30-.72) with significant heterogeneity (Q = 71.3, P < .01). CONCLUSIONS: Despite major inherent limitations of meta-analyses of cross-sectional studies, we believe that the data contribute to the formulation of the hypothesis that Cd explains, in part, why smokers have an increased risk of cardiovascular disease. Further research, including analytic studies designed a priori are necessary to test the hypothesis.


Assuntos
Cádmio/sangue , Doenças Cardiovasculares/etiologia , Fumar/efeitos adversos , Animais , Doenças Cardiovasculares/epidemiologia , Endotélio Vascular/patologia , Humanos , Fatores de Risco , Fumaça/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...